RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Ashland, WI · Hayward, WI · +452 more sites
Leukemia clinical trials in Madison, WI
12 recruiting leukemia studies with a site in Madison, WI.
RecruitingPhase 2NCT06317649
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Appleton, WI · Ashland, WI · Green Bay, WI · +222 more sites
RecruitingPhase 3NCT06136559
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Sponsor: Merck Sharp & Dohme LLC
Madison, WI · +47 more sites
RecruitingPhase 2NCT06672146
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Ashland, WI · Green Bay, WI · +132 more sites
RecruitingPhase 3NCT07007312
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Sponsor: Kura Oncology, Inc.
Madison, WI · Milwaukee, WI · +42 more sites
RecruitingPhase 3NCT04293562
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Sponsor: Children's Oncology Group
Green Bay, WI · Madison, WI · Marshfield, WI · +183 more sites
RecruitingPhase 1 / Phase 2NCT04726241
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Sponsor: PedAL BCU, LLC
Madison, WI · Marshfield, WI · +162 more sites
RecruitingPhase not listedNCT05702645
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Sponsor: Children's Oncology Group
Madison, WI · Marshfield, WI · Milwaukee, WI · +69 more sites
RecruitingNot applicableNCT06771830
Evaluation of Pediatric eCART Implementation
Sponsor: University of Wisconsin, Madison
Madison, WI
RecruitingPhase 1NCT05101551
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Sponsor: Norman J. Lacayo
Madison, WI · +8 more sites
RecruitingPhase 1NCT06501196
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Sponsor: BlossomHill Therapeutics
Madison, WI · +12 more sites
RecruitingPhase 1 / Phase 2NCT04150497
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Sponsor: Cellectis S.A.
Madison, WI · +13 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.